Andrew Witty, chief executive officer at GlaxoSmithKline (NYSE: GSK) gave an update overview about the state of the drug giant on Wednesday in an interview with CNBC.

“We’re seeing an emergence that looks like essentially Europe and the U.S. stabilizing,” Witty said.

“Very strong growth in the emerging markets in our pharmaceutical business.

“Very good global growth in our consumer health business, and very strong growth in our vaccine business.

“The net of all that we’ve seen now over the last several quarters [is] an underlying growth rate emerging.”

Watch the full interview here.

GSK employs some 4,000 people at its U.S. headquarters in RTP.

Get the latest news alerts: Follow WRAL Tech Wire at Twitter.